Literature DB >> 7078523

Cell-mediated immunity and delayed-type hypersensitivity in Pseudomonas aeruginosa-infected mice.

M Campa, L Toca, S Lombardi, C Garzelli, V Colizzi, G Falcone.   

Abstract

In mice repeated systemic injections of Pseudomonas aeruginosa viable cells were able to induce a specific delayed-type hypersensitivity, which was evaluated as increase both in footpad swelling and in the weight of popliteal lymph nodes, after a challenge in the footpad. Unfractionated spleen cells or T lymphocyte-enriched spleen cells from sensitized donors were able to specifically transfer the delayed-type hypersensitivity to syngeneic recipients but failed to protect them against a lethal challenge with P. aeruginosa. In contrast, serum or B lymphocyte and macrophage-enriched spleen cells from the same donors were capable of transferring protective immunity but failed to induce any delayed-type hypersensitivity reaction in the recipients. These results clearly show that in systemic P. aeruginosa infections a dissociation between delayed-type hypersensitivity and acquired cellular resistance occurs.

Entities:  

Mesh:

Year:  1982        PMID: 7078523     DOI: 10.1007/bf02298199

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  29 in total

1.  Cell-mediated immune responses to Pseudomonas aeruginosa.

Authors:  A M Munster; A G Leary
Journal:  Am J Surg       Date:  1977-06       Impact factor: 2.565

2.  Pulmonary host defenses in rabbits after immunization with Pseudomonas antigens: the interaction of bacteria, antibodies, macrophages, and lymphocytes.

Authors:  H Y Reynolds
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

3.  Detection of a graft-versus-host reaction between mice compatible at the H-2 locus.

Authors:  M H Salaman; N Wedderburn; H Festenstein; B Huber
Journal:  Transplantation       Date:  1973-07       Impact factor: 4.939

4.  Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.

Authors:  R G Neiburger; G P Youmans; A S Youmans
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

5.  Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.

Authors:  C L Pierson; A G Johnson; I Feller
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

6.  Depression of contact sensitivity by Pseudomonas aeruginosa-induced suppressor cells which affect the induction phase of immune response.

Authors:  C Garzelli; V Colizzi; M Campa; L Bozzi; G Falcone
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

7.  Induction and specificity of delayed hypersensitivity to Staphylococcus aureus in mice.

Authors:  J L Tribble; J B Bolen
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

8.  Mouse footpad infection by Pseudomonas aeruginosa: evidence for delayed hypersensitivity to specific bacterial antigen.

Authors:  C Garzelli; V Colizzi; M Campa; G Falcone
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  2 in total

1.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Impairment of cell-mediated immunity in Pseudomonas aeruginosa pyelonephritis: lack of suppressor cell activity in vivo.

Authors:  V Colizzi; M Campa; C Garzelli; L Toca; G Bevilacqua; G Falcone
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.